Sage Journals: Discover world-class research

Abstract

Web 2.0 applications and tools include blogs, podcasts, wikis and social networking communities. These tools, especially blogs and wikis, have been rapidly adopted by internet-savvy patients as a source of information and discourse about medical conditions and treatment options. Information via these applications has had an impact on patients' choices about their healthcare. In response, opportunities with Web 2.0 have been explored by pharmaceutical companies and medical institutions. These companies believe that Web 2.0 and Patient 2.0 tools offer an innovative way to connect with physicians and patients. Additionally, Web 2.0 can be a new method for marketing to consumers in an era where the return on investment is falling with more traditional channels. Neither the Food and Drug Administration nor Federal Trade Commission (FTC), however, has released firm guidance for Web 2.0 communications. Therefore, pharmaceutical companies are reticent regarding adoption of Web 2.0 for fear of a poor risk-benefit ratio and a lack of documented success with these tools. There are two primary concerns voiced when marketing via Web 2.0: off-label promotion and adverse event reporting. This paper provides an overview of Web 2.0, details associated regulatory risks and illustrates select strategies to help navigate these largely unexplored, but potentially powerful mechanisms to reach prescribers and patients.

Get full access to this article

View all access options for this article.

References

Boulos

Maramba

Wheeler

(2006). Wikis, blogs and podcasts: A new generation of Web-based tools for virtual collaborative clinical practice and education. BMC Med. Educ. 6, 41.

Markoff

(2006). Entrepreneurs see a web guided by common sense. NY Times. http://www.nytimes.com/2006/11/12/business/12web.html, accessed 5th May, 2008.

McLean

Richards

B. H.

Wardman

J. I.

(2007). The effect of Web 2.0 on the future of medical practice and education: Darwikinian evolution or folksonomic revolution? MJA 187, 174–177.

Nail

Serio

Johnmar

(2007) Connecting with patients, overcoming uncertainty (white paper), 2nd Annual eCommunication and Online Marketing Conference (Eyeforpharma), Philadelphia, USA.

O'Reilly

What is Web 2.0? Design patterns and business models for the next generation of software, http://oreillynet.com/pub/a/oreilly/tim/news/2005/09/30/what-is-web-20.html, accessed 5th May, 2008.

Taylor-Mendes

(2007). Proceed with caution: Using Wikipedia as a reference. Neonatal. Netw. 26, 140–141.

Media Wiki, http://www.mediawiki.org/wiki/MediaWiki, accessed 5th May, 2008.

Compete. Site analytics, http://siteanalytics.compete.com/wikipedia.org+myspace.com+yahoo.com/?metric=uv, accessed 5th May, 2008.

Roner

(2007). Web 2.0 – A new frontier for pharma? Eyeforpharma report, http://www.manhattanresearch.com/files/PRESS/eyeforpharmaWeb2_0report030107.pdf, accessed 5th May, 2008.

10.

Rost

Abbott caught altering entries to Wikipedia, 30th August, 2007. http://www.brandweeknrx.com/2007/08/abbott-caught-a.html, accessed 5th May, 2008.

11.

Bonetta

(2007). Scientists enter the blogosphere. Cell 129, 443–445.

12.

Niles

(2006). Lost in the blog. MedAdNews. http://www.pharmalive.com/magazines/medad/view.cfm?articleID=3686#, accessed 5th May, 2008.

13.

Gladwell

(2000). The Tipping Point: How Little Things Make a Big Difference, Little, Brown and Company, London, UK.

14.

Sé

A. B.

Passos

R. M.

Ono

A. H.

Hermes-Lima

(2008). The use of multiple tools for teaching medical biochemistry. Adv. Physiol. Educ. 32, 38–46.

15.

Jacobs

(2007). Hospital CEO raises awareness through blog. Profiles. Healthc. Commun. 23, 9–11, 2.

16.

Berger

(2007). Emergency medicine in the blogosphere: The irreverent wit of the specialty's unofficial voice. Ann. Emerg. Med. 49, 612–614.

17.

Bard

(Interview 17th May 2007). Pharma, physicians, and web 2.0? Are we there yet?’, Manhattan Research Center, http://www.talk.pharma-mkting.com/show016.htm, accessed 5th May, 2008.

18.

Clauson

K. A.

Vidal

D. M.

(2008). Overview of biomedical journal podcasts. Am. J. Health. Syst. Pharm. 65, 15, in press.

19.

Skiba

D. J.

(2006). The 2005 word of the year: Podcast. Nurs. Educ. Perspect. 27, 54–55.

20.

The Diffusion Group Research. Podcasting users to approach 60 million US consumers by 2010, http://www.tdgresearch.com/press044.htm, accessed 5th May, 2008.

21.

Abreu

D. V.

Tamura

T. K.

Sipp

J. A.

Keamy

D. G.

Jr Eavey

R. D.

(2008). Podcasting: Contemporary patient education. Ear Nose Throat J. 87 208, 210–211.

22.

Palmer

E. J.

Devitt

P. G.

(2007). A method for creating interactive content for the iPod, and its potential use as a learning tool: Technical advances. BMC Med. Educ. 22, 32.

23.

O'Donnel

(2007). ‘Patient 2.0: Welcome to your new customer’, 2nd Annual eCommunication and Online Marketing Conference (Eyeforpharma), Philadelphia, USA.

24.

Shore

E. E.

(2008). ‘Giving medical advice on social networking sites’, Medical Economics. http://medicaleconomics.modernmedicine.com/memag/Medical+Malpractice:+Risk+Management/Giving-medical-advice-on-social-networking-sites/ArticleStandard/Article/detail/494100, accessed 22nd May, 2008.

25.

Heywood

Palestrant

Reese

McQuigg

(2007). ‘Super media super panel’, 2nd Annual eCommunication and Online Marketing Conference (Eyeforpharma), Philadelphia, USA.

26.

Arnold

(2007). AMA enters online forum with Sermo. Med. Market. Media 42, 16.

27.

Anon (2007). With Sermo deal, Pfizer looks to reach docs off-hours. Med. Market. Media 11, 8.

28.

Phillips

(2007) Pharmaceutical marketing online: Stuck in Web 1.5 report, http://www.emarketer.com/Reports/All/Emarketer_2000434.aspx?src=report_head_info_reports, accessed 5th May, 2008.

29.

Iskowitz

(2008). A measure of success. Med. Market. Media, 43, S1, 8.

30.

Schehr

(2005). ‘Should pharmaceutical companies focus more on building brands or building relationships to get the highest ROI?’, Lathian Systems Report, http://pharmamkting.blogspot.com/2005/06/edetailing-roi-better-than-dtc.html, accessed 28th July, 2008.

31.

Weaver

Willy

Avigan

(2008). Informatic tools and approaches in postmarketing pharmacovigilance used by FDA. AAPS J. 10, 35–41.

32.

Guidance for Industry Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines (2001), US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER).

33.

Bryant

P.J.

(2001). ‘CTI: Process and lessons learned’, Canadian Technology Network, Canada Institute for Scientific and Technical Information and Federal Partners in Technology Transfer, Competitive Intelligence Conference, http://www.fptt-pftt.gc.ca/eng/resources/fptt_events/2001/workshops/docs/Bryant.ppt, accessed 29th May, 2008.

34.

Heutschi

Legner

Schiesser

Barak

Österle

(2003). Potential benefits and challenges of e-detailing in Europe. Int. J. Med. Market. 3, 263–273.

35.

Reuters Business Insight Health Care (2003). Physician – Targeted Internet Promotion: Online Solutions to Declining Productivity in the Sales Process, London, UK.

36.

Doyle

(2007). ‘Online marketing and e-detailing Europe’, In-depth report from an Eyeforpharma conference held in Berlin, 18-19th April, 2007.

37.

Bates

(2006). Online marketing and e-detailing Europe’, In-depth report from an Eyeforpharma conference held in Berlin, 8-19th May, 2006.

38.

Hummel

‘European patience’, 22nd May 2008. http://hivehealth.com/tag/regulations/, accessed 28th July, 2008.

39.

Anonymous (2008). Tracking Pharma consumers online. Pharma. Exec. 28, 98–100.

Legal and Regulatory Risk Associated with Web 2.0 Adoption by Pharmaceutical Companies

Abstract

Get full access to this article

References